In the results of advanced atherosclerosis mice, GLSP was able to downregulate fatty acid synthesis-related genes (FASN, PPARγ, SCD1) and upregulate fatty acid catabolism-related genes (HSL) (Figure 6F). This evidence concerns the gene FASN and atherosclerosis.